ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
President Cam Gallagher sold $730K of Zentalis Pharmaceuticals, Inc.
Sold$729,506
$26.27Price
27,768Shares
−6%Stake
What ZNTL did after the filing
- The stock from Thu, Jun 1 open, $25.95
- +6.0%
- S&P 500, same days
- +8.2%
Measured over 30 trading days, to the Jul 17 close.
Traded Wed, May 31. Filed Wed, May 31, 5:10 PM ET, after the close. Returns use the Jun 1 open and the Jul 17 close. Not investment advice.